telmisartan has been researched along with homocysteine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Melhim, WN; Al-Sultan, AI; Fouad, AA; Qureshi, HA; Yacoubi, MT | 1 |
| Bhalodia, Y; Jivani, N; Sheth, N; Vaghasiya, J | 1 |
| Huang, M; Song, H; Wang, K; Xie, L; Xu, C; Xu, S | 1 |
| Arru, D; Assaretti, S; Baralla, A; Carru, C; Ena, S; Mangoni, AA; Satta, AE; Sotgia, S; Sotgiu, E; Zinellu, A | 1 |
| Guo, J; Jia, Y; Li, S; Zhu, Z | 1 |
1 trial(s) available for telmisartan and homocysteine
| Article | Year |
|---|---|
Effects of Ramipril and Telmisartan on Plasma Concentrations of Low Molecular Weight and Protein Thiols and Carotid Intima Media Thickness in Patients with Chronic Kidney Disease.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Carotid Arteries; Cysteine; Drug Combinations; Female; Homocysteine; Humans; Male; Middle Aged; Ramipril; Renal Insufficiency, Chronic; Telmisartan; Tunica Intima | 2016 |
4 other study(ies) available for telmisartan and homocysteine
| Article | Year |
|---|---|
Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Benzimidazoles; Benzoates; Blood Pressure; Blood Urea Nitrogen; Caspase 3; Catalase; Creatinine; Disease Models, Animal; Glutathione; Homocysteine; Kidney; Kidney Diseases; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase; Telmisartan; Tumor Necrosis Factor-alpha | 2010 |
Role of fenofibrate alone and in combination with telmisartan on renal ischemia/reperfusion injury.
Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biomarkers; Drug Therapy, Combination; Fenofibrate; Homocysteine; Hypolipidemic Agents; Kidney; Kidney Function Tests; Male; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury; Telmisartan | 2010 |
Telmisartan inhibits the proinflammatory effects of homocysteine on human endothelial cells through activation of the peroxisome proliferator-activated receptor-δ pathway.
Topics: Benzimidazoles; Benzoates; Chemokine CCL2; Gene Expression Regulation; HL-60 Cells; Homocysteine; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Inflammation Mediators; NF-kappa B; PPAR delta; Protein Transport; RNA, Messenger; Signal Transduction; Telmisartan; Thiazoles; Vascular Cell Adhesion Molecule-1 | 2014 |
Homocysteine promotes migration of adventitial fibroblasts via angiotensin II type 1 receptor activation to aggravate atherosclerosis.
Topics: Adventitia; Atherosclerosis; Fibroblasts; Homocysteine; Humans; Hyperhomocysteinemia; Receptor, Angiotensin, Type 1; Telmisartan | 2022 |